NCT07080216RecruitingPhase 1/2
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
A Multicenter, Open-label, Dose-finding and Dose-expansion Phase I/II Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
Source: ClinicalTrials.gov · Last updated 5 Jan 2026
Brief summary (registry, in English)
This is a multicenter, open-label phase I/II study in patients with advanced cervical cancer designed to evaluate the safety, tolerability, and preliminary efficacy of ZG005 in combination with Gecacitinib ± bevacizumab.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 14 Jul 2025
- Start date
- Sept 2025
- Primary completion date
- Aug 2027
- Lead sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Diseases
- Cervical cancer
- NCT number
- NCT07080216
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 120
- From Sept 2025 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients were deemed unsuitable for participating in the study by the investigator for any reasons.
Who the study is looking for
- Fully understand the study and voluntarily sign the informed consent form.
- Female 18-75 years of age;
- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.
- Histologically or cytologically confirmed advanced cervical cancer, including squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhejiang Cancer Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.